Search Results - "Kuriyama, Haruka"

Refine Results
  1. 1
  2. 2

    Matrin-3 plays an important role in cell cycle and apoptosis for survival in malignant melanoma by Kuriyama, Haruka, Fukushima, Satoshi, Kimura, Toshihiro, Okada, Etsuko, Ishibashi, Takayuki, Mizuhashi, Satoru, Kanemaru, Hisashi, Kajihara, Ikko, Makino, Katsunari, Miyashita, Azusa, Aoi, Jun, Okada, Seiji, Ihn, Hironobu, Kita, Kanako

    Published in Journal of dermatological science (01-11-2020)
    “…•Matrin-3 was highly expressed in malignant melanoma (MM).•Matrin-3 knockdown inhibited the proliferation of melanoma cells.•Matrin-3 knockdown led to an…”
    Get full text
    Journal Article
  3. 3

    Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells by Mizuhashi, Satoru, Fukushima, Satoshi, Ishibashi, Takayuki, Kuriyama, Haruka, Kimura, Toshihiro, Kanemaru, Hisashi, Kajihara, Ikko, Makino, Katsunari, Miyashita, Azusa, Aoi, Jun, Kita, Kanako, Ihn, Hironobu

    Published in Journal of dermatological science (01-04-2021)
    “…•NAP1L4 was overexpressed in melanoma.•NAP1L4 knockdown reduced cell migration and invasion.•NAP1L4 knockdown upregulated p21 and downregulated Slug.•NAP1L4…”
    Get full text
    Journal Article
  4. 4

    Future prospects for cancer immunotherapy using induced pluripotent stem cell‐derived dendritic cells or macrophages by Fukushima, Satoshi, Miyashita, Azusa, Kuriyama, Haruka, Kimura, Toshihiro, Mizuhashi, Satoru, Kubo, Yosuke, Nakahara, Satoshi, Kanemaru, Hisashi, Tsuchiya, Nobuhiro, Mashima, Hiroaki, Zhang, Rong, Uemura, Yasushi

    Published in Experimental dermatology (01-03-2023)
    “…Cancer immunotherapy is now the first‐line treatment for many unresectable cancers. However, it remains far from a complete cure for all patients. Therefore,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    A Japanese case of melanoma of unknown origin with a rare BRAFV600R mutation was successfully treated with BRAF/MEK inhibitors by Kuriyama, Haruka, Kimura, Toshihiro, Mizuhashi, Satoru, Nishimura, Yuki, Kanemaru, Hisashi, Kajihara, Ikko, Makino, Katsunari, Aoi, Jun, Matsui, Hirotaka, Fukushima, Satoshi

    Published in Drug Discoveries & Therapeutics (31-10-2022)
    “…Combination therapy with BRAF and MEK inhibitors (BRAF/MEKi) has shown significantly prolonged progression-free survival (PFS) and overall survival (OS) for…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Metastasis to hypopharynx from epidermotropic metastatic malignant melanoma by Mizuhashi, Satoru, Miyashita, Azusa, Kuriyama, Haruka, Kimura, Toshihiro, Kanemaru, Hisashi, Miyamaru, Satoru, Saeki, Sho, Fukushima, Satoshi

    Published in Drug Discoveries & Therapeutics (30-04-2024)
    “…Previous reports proposed the concept and criteria of epidermotropic metastatic malignant melanoma (EMMM): (a) dermal involvement equal to or broader than the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Methyl-CpG binding domain protein 3: a new diagnostic marker and potential therapeutic target of melanoma by Ishibashi, Takayuki, Kajihara, Ikko, Mizuhashi, Satoru, Kuriyama, Haruka, Kimura, Toshihiro, Kanemaru, Hisashi, Makino, Katsunari, Miyashita, Azusa, Aoi, Jun, Makino, Takamitsu, Fukushima, Satoshi, Kita, Kanako, Ihn, Hironobu

    Published in BioScience Trends (31-10-2020)
    “…Methyl-CpG binding domain protein 3 (MBD3) belongs to the methyl-CpG binding protein family. MBD3 facilitates the initiation of neural stem cell reprogramming…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A mechanism of cooling hot tumors: Lactate attenuates inflammation in dendritic cells by Kanemaru, Hisashi, Mizukami, Yukari, Kaneko, Akira, Tagawa, Hidemi, Kimura, Toshihiro, Kuriyama, Haruka, Sawamura, Soichiro, Kajihara, Ikko, Makino, Katsunari, Miyashita, Azusa, Aoi, Jun, Makino, Takamitsu, Masuguchi, Shinichi, Fukushima, Satoshi, Ihn, Hironobu

    Published in iScience (24-09-2021)
    “…Turning non-inflamed (cold) tumors into inflamed (hot) tumors is important for maximizing the effect of immune checkpoint inhibitors (ICIs) against…”
    Get full text
    Journal Article
  15. 15

    Brain abscess in an angiosarcoma patient during a disease-free interval by Kuriyama, Haruka, Kajihara, Ikko, Kanemaru, Hisashi, Nishimura, Yuki, Igata, Toshikatsu, Masuguchi, Shinichi, Imaoka, Yukihiro, Makino, Keishi, Ihn, Hironobu

    Published in Drug Discoveries & Therapeutics (30-06-2019)
    “…This is the first case of an angiosarcoma patient with brain abscess, and it might be responsible for skin defect and cranial bone necrosis by surgical…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Deciphering the role of adjuvant therapy in melanoma and its actual benefits by Fukushima, Satoshi, Miyashita, Azusa, Kimura, Toshihiro, Kuriyama, Haruka, Mizuhashi, Satoru, Ichigozaki, Yuki, Masuguchi, Shinichi

    Published in Journal of dermatology (01-03-2024)
    “…Numerous clinical trials have demonstrated a significant improvement in recurrence‐free survival among melanoma patients receiving high‐dose interferon‐α,…”
    Get full text
    Journal Article
  19. 19

    Metastasis to hypopharynx from epidermotropic metastatic malignant melanoma by Mizuhashi, Satoru, Miyashita, Azusa, Kuriyama, Haruka, Kimura, Toshihiro, Kanemaru, Hisashi, Miyamaru, Satoru, Saeki, Sho, Fukushima, Satoshi

    Published in Drug Discoveries & Therapeutics (2024)
    “…Previous reports proposed the concept and criteria of epidermotropic metastatic malignant melanoma (EMMM): (a) dermal involvement equal to or broader than the…”
    Get full text
    Journal Article
  20. 20